Open Access<p>Evaluation of Medication Adherence and Rescue Medication Use in Non-Exacerbating Patients with COPD Receiving Umeclidinium/Vilanterol or Budesonide/Formoterol as Initial Maintenance Therapy</p>
Author(s) -
Chad Moretz,
Ashley L. Cole,
George Mu,
Benjamin Wu,
Amy Guisinger,
Yunhao Liu,
Beth Hahn,
Lee Baylis
Publication year - 2020
Publication title -
international journal of chronic obstructive pulmonary disease/international journal of copd
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.394
H-Index - 67
eISSN - 1178-2005
pISSN - 1176-9106
DOI - 10.2147/copd.s259850
Subject(s) - medicine , formoterol , copd , budesonide , rescue therapy , maintenance therapy , budesonide/formoterol , dry powder inhaler , asthma , inhaler , anesthesia , physical therapy , chemotherapy
Adherence to inhaled maintenance therapy is critical to managing chronic obstructive pulmonary disease (COPD), while increasing rescue medication usage may indicate worsening symptoms. This study evaluated adherence and rescue medication use in patients with COPD without a history of exacerbation who initiated combination therapy with budesonide/formoterol (B/F) or umeclidinium/vilanterol (UMEC/VI).